Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
Cooley advised Drata on the deal. Drata, a continuous security and compliance automation platform, announced its $200 million Series C funding round. The latest round of funding,...
You must be a Standard 1 Year member to access this content.
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Instructure on the deal. Instructure, a Thoma Bravo-owned education technology company, announced its agreement to sell Bridge, an employee learning, performance and skills development...
You must be a Standard 1 Year member to access this content.
